JAX-NYSCF at ISSCR 2026
Meet us at Booth #605
Join The Jackson Laboratory at ISSCR 2026 to explore how cutting-edge stem cell technologies are accelerating breakthroughs in research and human health. Discover a uniquely rigorously curated and rapidly expanding iPSC collection designed to power your next discovery. Learn about the fully automated, high throughput Global Stem Cell Array® used for stem cell reprogramming, genome editing, and differentiation. Whether you're pushing the boundaries of disease modeling, therapeutic development, or scientific innovation, our iPSC resources help you move faster with confidence. Visit our booth to experience the latest innovations and connect with experts turning bold ideas into real-world impact.
Register to Attend our Innovation Showcase
A complimentary lunch will be provided to registered attendees for the event - register to ensure your spot, as space is limited.
Featured Event! Presentations at the Innovation Showcase
FROM POPULATION SCALE AI PHENOTYPING TO COMPLEX NEURAL SYSTEMS: SCALABLE IPSC PLATFORMS FOR NEURODEGENERATIVE DISEASE DISCOVERY
Wednesday, July 8, 2026 | 12:30 – 1:30 PM EST
ROOM 510a, LEVEL 5
Bradford Casey, Ph.D., The Michael J. Fox Foundation for Parkinson's Research, will provide an overview of MJFF‑supported efforts to advance scalable, human‑relevant iPSC models of Parkinson’s disease. He will highlight the development and availability of Parkinson’s Progression Markers Initiative (PPMI) iPSC resources, MJFF’s partnership with JAX‑NYSCF to deploy these lines in high‑throughput systems, and community access to associated large‑scale datasets.
Stefan Semrau, Ph.D., JAX-NYSCF, will discuss an automated, high‑throughput strategy for in vitro Parkinson’s disease modeling. Robotic iPSC expansion and neuronal differentiation were used to profile 309 iPSC lines spanning PD patients from the MJFF’s PPMI cohort, matched controls, and genetically engineered risk variants. High‑content imaging enabled AI‑based disease classification from cellular morphology, complemented by disease‑ and variant‑specific molecular profiles derived from bulk RNA‑sequencing.
Anna Maria Schreiber, University of Alabama at Birmingham, will discuss the use of isogenic iPSC models to investigate neurodegenerative and early developmental disorders, with a focus on ALS and YWHAG syndrome. Using advanced 2D and 3D neural systems, she will show how these models recapitulate disease‑relevant pathology and uncover new biology.
JAX/NYSCF Posters and Presentations: Coming Soon!
Copyright © 2026, The Jackson Laboratory, All rights reserved.